Jiro Usuki

2.2k total citations
44 papers, 1.6k citations indexed

About

Jiro Usuki is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Oncology. According to data from OpenAlex, Jiro Usuki has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 8 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Jiro Usuki's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (29 papers), Pleural and Pulmonary Diseases (8 papers) and Medical Imaging and Pathology Studies (7 papers). Jiro Usuki is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (29 papers), Pleural and Pulmonary Diseases (8 papers) and Medical Imaging and Pathology Studies (7 papers). Jiro Usuki collaborates with scholars based in Japan and United States. Jiro Usuki's co-authors include Arata Azuma, Shoji Kudoh, Koji Horiba, Victor J. Ferrans, Joel Moss, Kuniko Matsuda, Yuh Fukuda, Shoji Kudoh, Shinji Abe and Tatsuji Enomoto and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and Anesthesiology.

In The Last Decade

Jiro Usuki

42 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiro Usuki Japan 19 1.0k 709 282 242 205 44 1.6k
Laura Bergantini Italy 25 1.3k 1.3× 710 1.0× 230 0.8× 340 1.4× 155 0.8× 131 2.0k
Hiroshi Ohnishi Japan 21 714 0.7× 501 0.7× 230 0.8× 180 0.7× 90 0.4× 81 1.6k
Roland du Bois United Kingdom 13 1.0k 1.0× 736 1.0× 269 1.0× 99 0.4× 141 0.7× 23 1.3k
Felix Chua United Kingdom 18 1.0k 1.0× 282 0.4× 222 0.8× 188 0.8× 93 0.5× 67 1.5k
Brian M. Greenlee United States 7 513 0.5× 572 0.8× 161 0.6× 162 0.7× 71 0.3× 9 971
James N. Allen United States 19 1.3k 1.3× 507 0.7× 275 1.0× 92 0.4× 629 3.1× 33 1.8k
Manuel Quaresma Germany 20 2.8k 2.7× 1.2k 1.7× 419 1.5× 163 0.7× 402 2.0× 64 3.1k
Nükhet Tüzüner Türkiye 17 391 0.4× 198 0.3× 129 0.5× 256 1.1× 342 1.7× 66 1.5k
Francesca Lunardi Italy 21 683 0.7× 185 0.3× 161 0.6× 249 1.0× 191 0.9× 94 1.6k
Bogdan Jakieła Poland 23 569 0.6× 594 0.8× 364 1.3× 234 1.0× 333 1.6× 67 1.7k

Countries citing papers authored by Jiro Usuki

Since Specialization
Citations

This map shows the geographic impact of Jiro Usuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Usuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Usuki more than expected).

Fields of papers citing papers by Jiro Usuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiro Usuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Usuki. The network helps show where Jiro Usuki may publish in the future.

Co-authorship network of co-authors of Jiro Usuki

This figure shows the co-authorship network connecting the top 25 collaborators of Jiro Usuki. A scholar is included among the top collaborators of Jiro Usuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiro Usuki. Jiro Usuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inomata, Minoru, Koichiro Kamio, Arata Azuma, et al.. (2020). Rictor-targeting exosomal microRNA-16 ameliorates lung fibrosis by inhibiting the mTORC2-SPARC axis. Experimental Cell Research. 398(2). 112416–112416. 14 indexed citations
2.
Kamio, Koichiro, Arata Azuma, Kuniko Matsuda, et al.. (2018). Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation. Respiratory Research. 19(1). 71–71. 37 indexed citations
3.
Kamio, Koichiro, Arata Azuma, Jiro Usuki, et al.. (2017). XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts. Pulmonary Pharmacology & Therapeutics. 44. 61–69. 15 indexed citations
4.
Kamio, Koichiro, Jiro Usuki, Arata Azuma, et al.. (2015). Nintedanib modulates surfactant protein-D expression in A549 human lung epithelial cells via the c-Jun N-terminal kinase-activator protein-1 pathway. Pulmonary Pharmacology & Therapeutics. 32. 29–36. 14 indexed citations
5.
Abe, Shinji, Hiroki Hayashi, Kuniko Matsuda, et al.. (2011). Reduction in Serum High Mobility Group Box-1 Level by Polymyxin B-Immobilized Fiber Column in Patients with Idiopathic Pulmonary Fibrosis with Acute Exacerbation. Blood Purification. 32(4). 310–316. 53 indexed citations
6.
Abe, Shinji, Hiroki Hayashi, Kuniko Matsuda, et al.. (2010). Neutrophil Adsorption by Polymyxin B-Immobilized Fiber Column for Acute Exacerbation in Patients with Interstitial Pneumonia: A Pilot Study. Blood Purification. 29(4). 321–326. 54 indexed citations
7.
Enomoto, Tatsuji, Arata Azuma, Kazuyo Kaneko, et al.. (2009). Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection. Respirology. 15(1). 126–131. 67 indexed citations
8.
Azuma, Arata, Yingji Li, Chunyan Wang, et al.. (2008). EM703, A NEW DERIVATIVE OF ERYTHROMYCIN, INHIBITS TRANSFORMING GRWTH FACTOR-β SIGNALING IN HUMAN LUNG FIBROBLASTS. Experimental Lung Research. 34(6). 343–354. 13 indexed citations
9.
Azuma, Arata & Jiro Usuki. (2008). Novel therapy for idiopathic pulmonary fibrosis—How to evaluate the efficacy?. Respiratory Medicine CME. 1(2). 75–81. 2 indexed citations
10.
Azuma, Arata, Shinya Abe, Jiro Usuki, et al.. (2007). Epidemiology of sarcoidosis in Japan. European Respiratory Journal. 31(2). 372–379. 280 indexed citations
11.
Azuma, Arata, Jiro Usuki, Shinji Abe, et al.. (2006). EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts. Respiratory Research. 7(1). 16–16. 66 indexed citations
12.
Azuma, Arata, Shinji Abe, Jiro Usuki, et al.. (2004). Interferon-β Inhibits Bleomycin-Induced Lung Fibrosis by Decreasing Transforming Growth Factor-β and Thrombospondin. American Journal of Respiratory Cell and Molecular Biology. 32(2). 93–98. 66 indexed citations
13.
Azuma, Arata, et al.. (2003). Familial clustering of dendriform pulmonary ossification.. PubMed. 20(2). 152–4. 25 indexed citations
14.
15.
Usuki, Jiro, et al.. (2001). Influence of Hyperglycemia to the Severity of Pulmonary Fibrosis. CHEST Journal. 120(1). S71–S71. 13 indexed citations
16.
Horiba, Koji, Jiro Usuki, Nilo A. Avila, et al.. (1999). Comprehensive Evaluation of 35 Patients With Lymphangioleiomyomatosis. CHEST Journal. 115(4). 1041–1052. 225 indexed citations
17.
Matsumoto, Yutaka, et al.. (1999). Markers of Cell Proliferation and Expression of Melanosomal Antigen in Lymphangioleiomyomatosis. American Journal of Respiratory Cell and Molecular Biology. 21(3). 327–336. 103 indexed citations
18.
Balducci, Enrico, et al.. (1999). Selective Expression of RT6 Superfamily in Human Bronchial Epithelial Cells. American Journal of Respiratory Cell and Molecular Biology. 21(3). 337–346. 20 indexed citations
19.
Trawöger, Rudolf, Theodor Kolobow, Matteo Giacomini, et al.. (1997). Clearance of Mucus from Endotracheal Tubes during Intratracheal Pulmonary Ventilation . Anesthesiology. 86(6). 1367–1374. 24 indexed citations
20.
Usuki, Jiro & Yuh Fukuda. (1995). Evolution of three patterns of intra‐alveolar fibrosis produced by bleomycin in rats. Pathology International. 45(8). 552–564. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Bergantini Breakdown of academic impact, for papers by Hiroshi Ohnishi Breakdown of academic impact, for papers by Roland du Bois Breakdown of academic impact, for papers by Felix Chua Breakdown of academic impact, for papers by Brian M. Greenlee Breakdown of academic impact, for papers by James N. Allen Breakdown of academic impact, for papers by Manuel Quaresma Breakdown of academic impact, for papers by Nükhet Tüzüner Breakdown of academic impact, for papers by Francesca Lunardi Breakdown of academic impact, for papers by Bogdan Jakieła
Rankless by CCL
2026